GE HealthCare Technologies Inc.

GEHCNASDAQHealthcare● Active

$64.67

+$0.00(+0.00%)

Market Cap$29.4B

P/E Ratio—

52W High$89.77

52W Low$58.75

Avg Volume4.8M

Open$64.75

Beta0.86

Free Cash Flow Financials Revenue

GE HealthCare Technologies Inc. (GEHC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GEHC · free cash flow · updated Jun 8, 2026

Core FCF metrics

GEHC · FCF · TTM · margin & CAGR

Free cash flow was $1.51B for FY2025 (fiscal year ending 2025-12-31), down 2.8% year-over-year The FCF margin was 7.3%. Five-year CAGR stands at +1.1%.

FY2025 Free Cash Flow$1.51B▼ -2.8% YoY

Trailing 12M (TTM)$1.52Btrailing 4 quarters sum

FCF Margin7.3%$1.51B ÷ revenue

3-Year CAGR-5.8%FY2022 → FY2025

5-Year CAGR+1.1%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GEHC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.99B(482M)$1.51B▼ 2.8%7.3%

FY2024$1.95B(401M)$1.55B▼ 9.6%7.9%

FY2023$2.10B(387M)$1.71B▼ 4.9%8.8%

FY2022$2.11B(310M)$1.80B▲ +32.7%9.8%

FY2021$1.61B(248M)$1.36B▼ 4.8%7.7%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GEHC · P/FCF · FCF yield · FCF per share

GE HealthCare Technologies Inc. (GEHC) trades at a FCF yield of 5.17% and a price-to-free-cash-flow ratio of 19.4x. FCF per share stands at $3.33, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.17%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.33

TTM FCF ÷ Shares Outstanding

Price / FCF

x19.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x24.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

GEHC · cash flow statement · operating / investing / financing

For FY2025, GE HealthCare Technologies Inc. generated $1.99B in operating cash flow and spent 482M in capital expenditures, yielding $1.51B in free cash flow.

Operating Activities

+$1.99B

Cash from core business operations

2025-12-31

Investing Activities

−$1.05B

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$617.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.99B) − |CapEx| (482M) = FCF ($1.51B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GEHC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

GE HealthCare Technologies Inc.YOU

GEHC

$1.51B-2.8%7.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

GE HealthCare Technologies Inc. (GEHC) reported free cash flow of $1.51B for FY2025 (fiscal year ending 2025-12-31), down 2.8% year-over-year. The FCF margin was 7.3%.

Based on available data, GE HealthCare Technologies Inc. has maintained positive free cash flow for at least 7 fiscal year(s). FCF peaked at $1.80B in FY2022. The 5-year CAGR stands at +1.1%.

GE HealthCare Technologies Inc.'s FCF yield is 5.17% and price-to-FCF ratio is 19.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GEHC free cash flow · 8 questions

GE HealthCare Technologies Inc. free cash flow was $1.51B for FY2025, down 2.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.52B.

GEHC free cash flowGEHC FCFGEHC FCF 2025GEHC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · GE HealthCare Technologies Inc. · GE HealthCare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026